资讯

Who Is Bryan Johnson? Meet the Millionaire Biohacker 'Replacing His Blood' to Defy Ageing
In a world obsessed with staying young, one man is pushing the boundaries of what's possible. Tech millionaire Bryan Johnson ...
FDA 批准首个阿尔茨海默病血检——里程碑背后的谨慎
美国食品药品监督管理局（FDA）于2025年5月16日批准了首个用于辅助诊断阿尔茨海默病（AD）的血液检测试剂盒——Lumipulse G pTau217/β-淀粉样蛋白1-42血浆比值检测试剂盒，由日本富士莱必欧诊断公司（Fujirebio ...
The American Journal of Managed Care1 天
FDA Clears First Blood Test for Early Detection of Alzheimer-Linked Amyloid Plaques
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...
FDA approves first blood test to help screen for Alzheimer's disease
The Lumipulse G Plasma Ratio Test offers a new way to detect signs of Alzheimer's disease by identifying plaque proteins in ...
Healio1 天
FDA grants 510(k) clearance to in vitro blood-based Alzheimer’s biomarker device
The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...
FDA clears first blood test to detect Alzheimer's disease. What to know about Lumipulse.
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
News-Medical.Net on MSN12 天
New workflow enhances detection of low-abundant glycoproteins in blood plasma
A recent study published in Engineering presents a novel approach to analyzing the low-abundant N-glycoproteome in human blood plasma (HBP), which could significantly advance the discovery of plasma ...